In this issue:
New proposed guidelines for obesity diagnosis, staging & management
Setmelanotide for acquired hypothalamic obesity
AMOS2: bariatric surgery & cognitive functioning in adolescents with severe obesity
A Wi-Fi feedback system for weight loss
An SMS programme to improve adolescent eating behaviours
Generalised/abdominal obesity & microvascular complications in type 2 diabetes
STEPS 1-4: patient-reported QoL with semaglutide 2.4mg
Implications of undiagnosed obesity in primary care
3-month weight loss <37.7% predictive of suboptimal outcomes after laparoscopic sleeve gastrectomy
Previous use of anti-obesity medication & weight loss with semaglutide
Please login below to download this issue (PDF)